Published Erratum
doi: 10.1038/s41591-025-03709-4.
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Lindsay B Kilburn
1
, Dong-Anh Khuong-Quang
2
, Jordan R Hansford
3
4
, Daniel Landi
5
, Jasper van der Lugt
6
, Sarah E S Leary
7
, Pablo Hernáiz Driever
8
, Simon Bailey
9
, Sébastien Perreault
10
, Geoffrey McCowage
11
, Angela J Waanders
12
, David S Ziegler
13
14
15
, Olaf Witt
16
17
18
19
20
, Patricia A Baxter
21
, Hyoung Jin Kang
22
, Timothy E Hassall
23
, Jung Woo Han
24
, Darren Hargrave
25
, Andrea T Franson
26
, Michal Yalon Oren
27
, Helen Toledano
28
, Valérie Larouche
29
, Cassie Kline
30
, Mohamed S Abdelbaki
31
, Nada Jabado
32
, Nicholas G Gottardo
33
, Nicolas U Gerber
34
, Nicholas S Whipple
35
, Devorah Segal
36
, Susan N Chi
37
, Liat Oren
38
, Enrica E K Tan
39
, Sabine Mueller
40
, Izzy Cornelio
41
, Lisa McLeod
41
, Xin Zhao
41
, Ashley Walter
41
, Daniel Da Costa
41
, Peter Manley
41
, Samuel C Blackman
41
, Roger J Packer
42
, Karsten Nysom
43
Affiliations
Affiliations
- 1 Children's National Hospital, Washington, DC, USA. lkilburn@childrensnational.org.
- 2 Children's Cancer Centre, Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
- 3 Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
- 4 South Australia Health and Medical Research Institute, Adelaide, Australia; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.
- 5 Duke University, Durham, NC, USA.
- 6 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
- 7 Cancer and Blood Disorders Center, Seattle Children's, Seattle, WA, USA.
- 8 Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Berlin, German HIT-LOGGIC-Registry for LGG in Children and Adolescents, Berlin, Germany.
- 9 Great North Children's Hospital and Newcastle University Centre for Cancer, Newcastle-upon-Tyne, UK.
- 10 CHU Sainte-Justine, Université de Montréal, Montréal, Quebec, Canada.
- 11 Sydney Children's Hospitals Network, Westmead, New South Wales, Australia.
- 12 Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA.
- 13 Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.
- 14 Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
- 15 School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
- 16 Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
- 17 Clinical Cooperation Unit, Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 18 Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
- 19 German Cancer Consortium (DKTK), Heidelberg, Germany.
- 20 National Center for Tumor Diseases (NCT), Heidelberg, Germany.
- 21 Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
- 22 Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Republic of Korea.
- 23 Children's Health Queensland Hospital and Health Service, South Brisbane, QLD, Australia.
- 24 Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea.
- 25 UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.
- 26 C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, MI, USA.
- 27 Pediatric Hemato-Oncology, Sheba Medical Center, Ramat Gan, Israel.
- 28 Department of Pediatric Oncology, Schneider Children's Medical Center, Petach Tikva, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- 29 Department of Pediatrics, Centre Mère-Enfant Soleil du CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
- 30 Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- 31 Division of Hematology and Oncology, Department of Pediatrics, School of Medicine, Washington University, St. Louis, MO, USA.
- 32 McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH), Montreal, Quebec, Canada.
- 33 Department of Pediatric and Adolescent Oncology and Hematology, Perth Children's Hospital, Perth, Australia, and Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
- 34 Department of Oncology, University Children's Hospital, Zurich, Switzerland.
- 35 Primary Children's Hospital and University of Utah, Salt Lake City, UT, USA.
- 36 NYU Langone Health, New York, NY, USA.
- 37 Pediatric Neuro-Oncology, Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
- 38 Department of Hematology & Oncology, Rambam Healthcare Campus, Haifa, Israel.
- 39 Haematology/Oncology Service, KK Women's and Children's Hospital, Singapore, Singapore.
- 40 Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
- 41 Day One Biopharmaceuticals, Brisbane, CA, USA.
- 42 Division of Neurology, Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC, USA.
- 43 Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- PMID: 40240838
- PMCID: PMC12283413
- DOI: 10.1038/s41591-025-03709-4
Item in Clipboard
Published Erratum
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Lindsay B Kilburn et al.
Nat Med.
2025 Jul.
Display options
Format
doi: 10.1038/s41591-025-03709-4.
Authors
Lindsay B Kilburn
1
, Dong-Anh Khuong-Quang
2
, Jordan R Hansford
3
4
, Daniel Landi
5
, Jasper van der Lugt
6
, Sarah E S Leary
7
, Pablo Hernáiz Driever
8
, Simon Bailey
9
, Sébastien Perreault
10
, Geoffrey McCowage
11
, Angela J Waanders
12
, David S Ziegler
13
14
15
, Olaf Witt
16
17
18
19
20
, Patricia A Baxter
21
, Hyoung Jin Kang
22
, Timothy E Hassall
23
, Jung Woo Han
24
, Darren Hargrave
25
, Andrea T Franson
26
, Michal Yalon Oren
27
, Helen Toledano
28
, Valérie Larouche
29
, Cassie Kline
30
, Mohamed S Abdelbaki
31
, Nada Jabado
32
, Nicholas G Gottardo
33
, Nicolas U Gerber
34
, Nicholas S Whipple
35
, Devorah Segal
36
, Susan N Chi
37
, Liat Oren
38
, Enrica E K Tan
39
, Sabine Mueller
40
, Izzy Cornelio
41
, Lisa McLeod
41
, Xin Zhao
41
, Ashley Walter
41
, Daniel Da Costa
41
, Peter Manley
41
, Samuel C Blackman
41
, Roger J Packer
42
, Karsten Nysom
43
Affiliations
- 1 Children's National Hospital, Washington, DC, USA. lkilburn@childrensnational.org.
- 2 Children's Cancer Centre, Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
- 3 Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
- 4 South Australia Health and Medical Research Institute, Adelaide, Australia; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.
- 5 Duke University, Durham, NC, USA.
- 6 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
- 7 Cancer and Blood Disorders Center, Seattle Children's, Seattle, WA, USA.
- 8 Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Berlin, German HIT-LOGGIC-Registry for LGG in Children and Adolescents, Berlin, Germany.
- 9 Great North Children's Hospital and Newcastle University Centre for Cancer, Newcastle-upon-Tyne, UK.
- 10 CHU Sainte-Justine, Université de Montréal, Montréal, Quebec, Canada.
- 11 Sydney Children's Hospitals Network, Westmead, New South Wales, Australia.
- 12 Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA.
- 13 Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.
- 14 Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
- 15 School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
- 16 Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
- 17 Clinical Cooperation Unit, Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 18 Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
- 19 German Cancer Consortium (DKTK), Heidelberg, Germany.
- 20 National Center for Tumor Diseases (NCT), Heidelberg, Germany.
- 21 Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
- 22 Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Republic of Korea.
- 23 Children's Health Queensland Hospital and Health Service, South Brisbane, QLD, Australia.
- 24 Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea.
- 25 UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.
- 26 C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, MI, USA.
- 27 Pediatric Hemato-Oncology, Sheba Medical Center, Ramat Gan, Israel.
- 28 Department of Pediatric Oncology, Schneider Children's Medical Center, Petach Tikva, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- 29 Department of Pediatrics, Centre Mère-Enfant Soleil du CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
- 30 Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- 31 Division of Hematology and Oncology, Department of Pediatrics, School of Medicine, Washington University, St. Louis, MO, USA.
- 32 McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH), Montreal, Quebec, Canada.
- 33 Department of Pediatric and Adolescent Oncology and Hematology, Perth Children's Hospital, Perth, Australia, and Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
- 34 Department of Oncology, University Children's Hospital, Zurich, Switzerland.
- 35 Primary Children's Hospital and University of Utah, Salt Lake City, UT, USA.
- 36 NYU Langone Health, New York, NY, USA.
- 37 Pediatric Neuro-Oncology, Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
- 38 Department of Hematology & Oncology, Rambam Healthcare Campus, Haifa, Israel.
- 39 Haematology/Oncology Service, KK Women's and Children's Hospital, Singapore, Singapore.
- 40 Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
- 41 Day One Biopharmaceuticals, Brisbane, CA, USA.
- 42 Division of Neurology, Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, DC, USA.
- 43 Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- PMID: 40240838
- PMCID: PMC12283413
- DOI: 10.1038/s41591-025-03709-4
Item in Clipboard
Display options
Format
No abstract available
Erratum for
-
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.Kilburn LB, Khuong-Quang DA, Hansford JR, Landi D, van der Lugt J, Leary SES, Driever PH, Bailey S, Perreault S, McCowage G, Waanders AJ, Ziegler DS, Witt O, Baxter PA, Kang HJ, Hassall TE, Han JW, Hargrave D, Franson AT, Yalon Oren M, Toledano H, Larouche V, Kline C, Abdelbaki MS, Jabado N, Gottardo NG, Gerber NU, Whipple NS, Segal D, Chi SN, Oren L, Tan EEK, Mueller S, Cornelio I, McLeod L, Zhao X, Walter A, Da Costa D, Manley P, Blackman SC, Packer RJ, Nysom K. Kilburn LB, et al. Nat Med. 2024 Jan;30(1):207-217. doi: 10.1038/s41591-023-02668-y. Epub 2023 Nov 17. Nat Med. 2024. PMID: 37978284 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
